penicillamine has been researched along with Anti-MuSK Myasthenia Gravis in 122 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After a controlled, double blind multicenter trial of D-penicillamine in the treatment of rheumatoid arthritis, 148 patients were followed for an additional year in an open label trial." | 9.06 | Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group. ( , 1987) |
| "We have encountered a 53 year-old female with myasthenia gravis (MG) possibly induced by the treatment with D-penicillamine (D-pc)." | 8.78 | [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis]. ( Hosoya, T; Kuriyama, S; Sakai, O, 1991) |
| "Between 1979 and 1990 we have seen 8 patients (7 females) with rheumatoid arthritis (RA) who developed a neuro-muscular involvement while on D-penicillamine (D." | 8.78 | [Neuromuscular complications of D-penicillamine in rheumatoid arthritis]. ( Bouchet, F; Bussière, JL; Dubost, JJ; Kemeny, JL; Lhopitaux, R; Sauvezie, B; Soubrier, M, 1992) |
| "A 68-year-old black woman who was put on D-penicillamine therapy (250-500 mg per day, total dose 15 g) for rheumatoid arthritis developed ocular myasthenia gravis." | 8.77 | Ocular myasthenia gravis after D-penicillamine administration. ( Katz, LJ; Lesser, RL; Merikangas, JR; Silverman, JP, 1989) |
| "d-penicillamine; myasthenia gravis; pyridostigmine; Wilson's disease." | 8.12 | D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report. ( Bhattarai, S; Paudel, R; Pokharel, M; Rai, N; Sharma, N; Shrestha, AM; Thapa, L; Thapa, M, 2022) |
| "A 67-year old woman who had been taking D-penicillamine for 15 months for rheumatoid arthritis was hospitalized due to the development of a bullous eruption and proximal muscle deficiency." | 7.70 | [D-penicillamine-induced pemphigus, polymyositis and myasthenia]. ( Callens, A; Jan, V; Lorette, G; Machet, L; Machet, MC; Vaillant, L, 1999) |
| "The anti-rheumatoid drug D-penicillamine (D-pen) has a reactive sulfhydryl group capable of modifying self antigens, and can provoke typical autoantibody-mediated myasthenia gravis (MG), especially in DR1+ individuals." | 7.70 | T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes. ( Hill, M; Moss, P; Newsom-Davis, J; Willcox, N; Wordsworth, P, 1999) |
| "Five patients out of 71 with rheumatoid arthritis (RA), who received D-penicillamine, developed myasthenia gravis (MG) within a two-year period." | 7.69 | D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence? ( Andonopoulos, AP; Papapetropoulos, T; Papasteriades, CA; Terzis, E; Tsibri, E, 1994) |
| "A 53-year-old woman with rheumatoid arthritis developed myasthenia gravis after 6 months of therapy with D-penicillamine." | 7.69 | D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis. ( Agelli, M; Bazzichi, L; Ciompi, ML; Marchetti, G; Puccetti, L, 1995) |
| "D-penicillamine has been used in the treatment of rheumatoid arthritis for years." | 7.69 | [D-penicillamine-induced myasthenia gravis]. ( Frey, RA; Keller, F; Michel, BA, 1994) |
| "D-penicillamine, a drug used to treat rheumatoid arthritis, Wilson's disease, and cystinuria, can cause myasthenia gravis." | 7.69 | D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease. ( Adelman, HM; Mahan, CS; Wallach, PM; Winters, PR, 1995) |
| "Myasthenia gravis may be observed due to treatment with penicillamine (D-PA)." | 7.69 | Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis. ( Ayesh, R; Seideman, P, 1994) |
| "We report a case of a 47-year-old woman with rheumatoid arthritis who developed ocular myasthenia gravis during penicillamine treatment." | 7.68 | Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis. ( Bienfang, DC; Liu, GT, 1990) |
| " Both patients (one case of progressive systemic sclerosis and one of rheumatoid arthritis) were currently taking D-penicillamine." | 7.68 | Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis. ( Fries, JF; Kornfeld, P; Lee, YS; Raynauld, JP, 1993) |
| "The distribution of autoantibodies was studied in patients with rheumatoid arthritis (RA) treated by D-penicillamine and who developed myasthenia gravis (MG)." | 7.68 | Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis. ( Bach, JF; Bataille, R; D'Anglejan, J; Feuillet-Fieux, MN; Morel, E; Raimond, F; Sany, J; Vernet-der Garabedian, B, 1991) |
| "A small fraction of patients with rheumatoid arthritis and other diseases on D-penicillamine treatment may develop antibodies against the acetylcholine receptor (AChR) and symptoms of myasthenia gravis (MG)." | 7.67 | Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis. ( Bustarret, AF; D'Anglejan, J; Drosos, AA; Efthimiadis, A; Morel, E; Moutsopoulos, HA; Tzartos, SJ, 1988) |
| "Three cases of D-penicillamine (DPA) induced myasthenia gravis (MG) and one case of DPA-induced polymyositis (PM) are reported among four patients suffering from seropositive rheumatoid arthritis." | 7.67 | Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis. ( De Bruyère, M; Devogelaer, JP; Huaux, JP; Isaac, G; Nagant de Deuxchaisnes, C; Noël, H, 1985) |
| "The development of autoimmune diseases in some patients treated with D-penicillamine (DPA) suggests that the reported occurrence of a conduction disorder at the neuromuscular junction and the development of a reversible myasthenia gravis in rheumatoid disease, progressive systemic sclerosis or Wilson's disease after the use of DPA are part of a general predisposition for autoimmune disease related to DPA therapy." | 7.67 | [Myasthenia gravis induced by D-penicillamine in a patient with progressive systemic sclerosis]. ( Cossermelli, W; De Assis, JL; Marchiori, PE; Scaff, M, 1984) |
| "The antigenic specificity of anti-acetylcholine receptor antibodies (anti-AChR) from 70 recent onset myasthenia gravis (MG) and nine penicillamine MG patients was determined by inhibition experiments using monoclonal antibodies (m." | 7.67 | Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myasthenia. ( Heidenreich, F; Newsom-Davis, J; Vincent, A, 1988) |
| "In a 3-centre study involving 144 patients with rheumatoid arthritis (RA), a relationship between side effects from D-penicillamine and HLA antigens, allotypic markers of the IgG heavy chain (Gm) and allotypes of complement components Bf, C4A and C4B was sought." | 7.67 | Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine. ( Hannah, MC; Major, GA; Mathews, JD; McCluskey, J; Muirden, KD; Property, DN; Stockman, A; Tait, BD; Zilko, PJ, 1986) |
| "Eight Australian cases of D-penicillamine induced polymyositis/dermatomyositis (PM/DM) are reported." | 7.67 | Penicillamine induced polymyositis and dermatomyositis. ( Carroll, GJ; Dawkins, RL; Garlepp, MJ; Peter, JB; Will, RK, 1987) |
| "We have described a unique patient who had reversible and dose-related myasthenia gravis after penicillamine and chloroquine therapy for rheumatoid arthritis." | 7.67 | Myasthenia gravis caused by penicillamine and chloroquine therapy for rheumatoid arthritis. ( Hearn, J; Tiliakos, NA, 1986) |
| "The case of a 57-year-old woman with rheumatoid arthritis is presented to illustrate the rare occurrence of a myasthenic syndrome induced by D-penicillamine, which led to prolonged (5." | 7.67 | D-penicillamine induced myasthenia gravis. Its relevance for the anaesthetist. ( Fried, MJ; Protheroe, DT, 1986) |
| "The temporal course and pathophysiology of penicillamine-induced myasthenia gravis were studied in detail in a typical case." | 7.67 | The pathophysiology of penicillamine-induced myasthenia gravis. ( Drachman, DB; Kuncl, RW; Pestronk, A; Rechthand, E, 1986) |
| "Two patients with rheumatoid arthritis (two women, 58 and 62 years old) developed reversible penicillamine-induced ocular myasthenia gravis." | 7.67 | Penicillamine-induced ocular myasthenia gravis. ( Haining, WM; Morley, KD; O'Keefe, M; Smith, A, 1985) |
| "Skin rashes, proteinuria, systemic lupus erythematosus, polymyositis and myasthenia gravis have all been recorded as complications of penicillamine therapy in patients with rheumatoid arthritis." | 7.66 | Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis. ( Essigman, WK, 1982) |
| "Electroneuromyographic studies have been reported as abnormal in only 9 of 23 cases of penicillamine-associated myasthenia gravis (MG)." | 7.66 | Penicillamine-associated myasthenia gravis. ( Albers, JW; Hodach, RJ; Kimmel, DW; Treacy, WL, 1980) |
| "Antibodies to the acetylcholine receptor and HLA antigens have been studied in patients with myasthenia gravis occurring in association with penicillamine treatment." | 7.66 | HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. ( Christiansen, FT; Dawkins, RL; Garlepp, MJ, 1983) |
| "The authors report on 2 personal cases, and review 48 published cases of myasthenia induced by D-penicillamine (D-P) treatment in patients with rheumatoid arthritis." | 7.66 | [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)]. ( Cler, JM; Cottin, S; Hamelin, JP; Lemouroux, P; Rodat, G; Rodat, O; Rossard, A, 1981) |
| "The clinical features and genetic background of 18 patients with rheumatoid arthritis were investigated following the development of penicillamine-induced myasthenia (PIM)." | 7.66 | Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features. ( Delamere, JP; Jobson, S; Mackintosh, LP; Walton, KW; Wells, L, 1983) |
| "This article reports some observations made in a woman who developed myasthenia gravis after treatment with D-penicillamine." | 7.66 | Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report. ( Naidoo, PD, 1981) |
| "Immunological and electrophysiological features were investigated in a patient with rheumatoid arthritis who developed myasthenic symptoms after 10 months of treatment with D-penicillamine (D-pen)." | 7.66 | D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies. ( Argov, Z; Fawcett, PR; Mastaglia, FL; McLachlan, SM; Nicholson, LV, 1982) |
| "A woman with rheumatoid arthritis was treated with penicillamine and developed myasthenia gravis." | 7.66 | Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor. ( Lindstrom, JM; Russell, AS, 1978) |
| "Autoimmune diseases, including myasthenia gravis, occur in patients treated with D-penicillamine." | 7.66 | Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. ( Bever, CT; Bock, E; Chang, HW; Jaffe, IA; Penn, AS, 1982) |
| "Myasthenia gravis with thymic hyperplasia developed in a patient with Wilson's disease after eight years of penicillamine treatment." | 7.65 | Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. ( Dawkins, RL; Leedman, RJ; Masters, CL; Simpson, JA; Zilko, PJ, 1977) |
| "A myasthenic reaction developed after an average latency of seven to eight months in 12 female patients (average age 51 years) treated with penicillamine for chronic rheumatoid arthritis." | 7.65 | [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)]. ( Hopf, HC; Janzen, RW; Meyer, W; Seitz, D, 1976) |
| ") developed myasthenia gravis after taking penicillamine." | 7.65 | Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. ( Bucknall, RC; Dixon A St, J; Glick, EN; Woodland, J; Zutshi, DW, 1975) |
| " Our patient is one of three siblings on Penicillamine, she was the only one who developed massive breast enlargement four months after commencing Penicillamine therapy, as well as dermatological adverse reactions and myasthenia gravis three more months later." | 5.38 | Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient. ( Latif, SA; Poh, WY; Tan, SS, 2012) |
| "After a controlled, double blind multicenter trial of D-penicillamine in the treatment of rheumatoid arthritis, 148 patients were followed for an additional year in an open label trial." | 5.06 | Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group. ( , 1987) |
| "Between 1979 and 1990 we have seen 8 patients (7 females) with rheumatoid arthritis (RA) who developed a neuro-muscular involvement while on D-penicillamine (D." | 4.78 | [Neuromuscular complications of D-penicillamine in rheumatoid arthritis]. ( Bouchet, F; Bussière, JL; Dubost, JJ; Kemeny, JL; Lhopitaux, R; Sauvezie, B; Soubrier, M, 1992) |
| "We have encountered a 53 year-old female with myasthenia gravis (MG) possibly induced by the treatment with D-penicillamine (D-pc)." | 4.78 | [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis]. ( Hosoya, T; Kuriyama, S; Sakai, O, 1991) |
| "A 68-year-old black woman who was put on D-penicillamine therapy (250-500 mg per day, total dose 15 g) for rheumatoid arthritis developed ocular myasthenia gravis." | 4.77 | Ocular myasthenia gravis after D-penicillamine administration. ( Katz, LJ; Lesser, RL; Merikangas, JR; Silverman, JP, 1989) |
| "d-penicillamine; myasthenia gravis; pyridostigmine; Wilson's disease." | 4.12 | D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report. ( Bhattarai, S; Paudel, R; Pokharel, M; Rai, N; Sharma, N; Shrestha, AM; Thapa, L; Thapa, M, 2022) |
| "The anti-rheumatoid drug D-penicillamine (D-pen) has a reactive sulfhydryl group capable of modifying self antigens, and can provoke typical autoantibody-mediated myasthenia gravis (MG), especially in DR1+ individuals." | 3.70 | T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes. ( Hill, M; Moss, P; Newsom-Davis, J; Willcox, N; Wordsworth, P, 1999) |
| "A 67-year old woman who had been taking D-penicillamine for 15 months for rheumatoid arthritis was hospitalized due to the development of a bullous eruption and proximal muscle deficiency." | 3.70 | [D-penicillamine-induced pemphigus, polymyositis and myasthenia]. ( Callens, A; Jan, V; Lorette, G; Machet, L; Machet, MC; Vaillant, L, 1999) |
| "A 53-year-old woman with rheumatoid arthritis developed myasthenia gravis after 6 months of therapy with D-penicillamine." | 3.69 | D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis. ( Agelli, M; Bazzichi, L; Ciompi, ML; Marchetti, G; Puccetti, L, 1995) |
| "Five patients out of 71 with rheumatoid arthritis (RA), who received D-penicillamine, developed myasthenia gravis (MG) within a two-year period." | 3.69 | D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence? ( Andonopoulos, AP; Papapetropoulos, T; Papasteriades, CA; Terzis, E; Tsibri, E, 1994) |
| "Myasthenia gravis may be observed due to treatment with penicillamine (D-PA)." | 3.69 | Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis. ( Ayesh, R; Seideman, P, 1994) |
| "D-penicillamine, a drug used to treat rheumatoid arthritis, Wilson's disease, and cystinuria, can cause myasthenia gravis." | 3.69 | D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease. ( Adelman, HM; Mahan, CS; Wallach, PM; Winters, PR, 1995) |
| "D-penicillamine has been used in the treatment of rheumatoid arthritis for years." | 3.69 | [D-penicillamine-induced myasthenia gravis]. ( Frey, RA; Keller, F; Michel, BA, 1994) |
| "We report a case of a 47-year-old woman with rheumatoid arthritis who developed ocular myasthenia gravis during penicillamine treatment." | 3.68 | Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis. ( Bienfang, DC; Liu, GT, 1990) |
| "The distribution of autoantibodies was studied in patients with rheumatoid arthritis (RA) treated by D-penicillamine and who developed myasthenia gravis (MG)." | 3.68 | Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis. ( Bach, JF; Bataille, R; D'Anglejan, J; Feuillet-Fieux, MN; Morel, E; Raimond, F; Sany, J; Vernet-der Garabedian, B, 1991) |
| " Both patients (one case of progressive systemic sclerosis and one of rheumatoid arthritis) were currently taking D-penicillamine." | 3.68 | Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis. ( Fries, JF; Kornfeld, P; Lee, YS; Raynauld, JP, 1993) |
| "Because of the association of D-penicillamine (DP) therapy with myasthenia gravis, we have studied long-term DP treatment in five inbred strains of mice with doses comparable to those used in patients with rheumatoid arthritis." | 3.67 | Augmented anti-acetylcholine receptor response following long-term penicillamine administration. ( Asofsky, R; Bever, CT; Blake, GJ; Chang, HW; Dretchen, KL; Penn, AS, 1984) |
| "Eight Australian cases of D-penicillamine induced polymyositis/dermatomyositis (PM/DM) are reported." | 3.67 | Penicillamine induced polymyositis and dermatomyositis. ( Carroll, GJ; Dawkins, RL; Garlepp, MJ; Peter, JB; Will, RK, 1987) |
| "Sera from 23 patients with D-penicillamine-induced myasthenia gravis (MG) contained antibodies directed against the human muscle acetylcholine receptor (anti-AChR) in 83% of the cases at the onset of the disease." | 3.67 | [Myasthenia induced by D-penicillamine. Study of immuno-clinical correlations in 23 cases]. ( Bach, JF; d'Anglejan, J; Feuillet-Fieux, MN; Jacob, L; Morel, E; Raimond, F; Vernet der Garabedian, B, 1985) |
| "Seven cases of myasthenia induced by D-penicillamine treatment of rheumatoid arthritis are presented." | 3.67 | [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis]. ( Carter, H; Delrieu, F; Job-Deslandre, C; Kahan, A; Menkès, CJ, 1986) |
| "We have described a unique patient who had reversible and dose-related myasthenia gravis after penicillamine and chloroquine therapy for rheumatoid arthritis." | 3.67 | Myasthenia gravis caused by penicillamine and chloroquine therapy for rheumatoid arthritis. ( Hearn, J; Tiliakos, NA, 1986) |
| "The case of a 57-year-old woman with rheumatoid arthritis is presented to illustrate the rare occurrence of a myasthenic syndrome induced by D-penicillamine, which led to prolonged (5." | 3.67 | D-penicillamine induced myasthenia gravis. Its relevance for the anaesthetist. ( Fried, MJ; Protheroe, DT, 1986) |
| "A small fraction of patients with rheumatoid arthritis and other diseases on D-penicillamine treatment may develop antibodies against the acetylcholine receptor (AChR) and symptoms of myasthenia gravis (MG)." | 3.67 | Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis. ( Bustarret, AF; D'Anglejan, J; Drosos, AA; Efthimiadis, A; Morel, E; Moutsopoulos, HA; Tzartos, SJ, 1988) |
| "The temporal course and pathophysiology of penicillamine-induced myasthenia gravis were studied in detail in a typical case." | 3.67 | The pathophysiology of penicillamine-induced myasthenia gravis. ( Drachman, DB; Kuncl, RW; Pestronk, A; Rechthand, E, 1986) |
| "The antigenic specificity of anti-acetylcholine receptor antibodies (anti-AChR) from 70 recent onset myasthenia gravis (MG) and nine penicillamine MG patients was determined by inhibition experiments using monoclonal antibodies (m." | 3.67 | Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myasthenia. ( Heidenreich, F; Newsom-Davis, J; Vincent, A, 1988) |
| "Two patients with rheumatoid arthritis (two women, 58 and 62 years old) developed reversible penicillamine-induced ocular myasthenia gravis." | 3.67 | Penicillamine-induced ocular myasthenia gravis. ( Haining, WM; Morley, KD; O'Keefe, M; Smith, A, 1985) |
| "The development of autoimmune diseases in some patients treated with D-penicillamine (DPA) suggests that the reported occurrence of a conduction disorder at the neuromuscular junction and the development of a reversible myasthenia gravis in rheumatoid disease, progressive systemic sclerosis or Wilson's disease after the use of DPA are part of a general predisposition for autoimmune disease related to DPA therapy." | 3.67 | [Myasthenia gravis induced by D-penicillamine in a patient with progressive systemic sclerosis]. ( Cossermelli, W; De Assis, JL; Marchiori, PE; Scaff, M, 1984) |
| "In a 3-centre study involving 144 patients with rheumatoid arthritis (RA), a relationship between side effects from D-penicillamine and HLA antigens, allotypic markers of the IgG heavy chain (Gm) and allotypes of complement components Bf, C4A and C4B was sought." | 3.67 | Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine. ( Hannah, MC; Major, GA; Mathews, JD; McCluskey, J; Muirden, KD; Property, DN; Stockman, A; Tait, BD; Zilko, PJ, 1986) |
| "Three cases of D-penicillamine (DPA) induced myasthenia gravis (MG) and one case of DPA-induced polymyositis (PM) are reported among four patients suffering from seropositive rheumatoid arthritis." | 3.67 | Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis. ( De Bruyère, M; Devogelaer, JP; Huaux, JP; Isaac, G; Nagant de Deuxchaisnes, C; Noël, H, 1985) |
| " Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis." | 3.66 | [Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia (author's transl)]. ( Baron, D; Blanloeil, Y; Gazeau, MF; Nicolas, F, 1980) |
| "D-penicillamine is a potent drug used to treat rheumatoid arthritis, Wilson's disease and cystinuria." | 3.66 | D-penicillamine and the ocular myasthenic syndrome. ( Kimbrough, RL; Mewis, L; Stewart, RH, 1981) |
| "This article reports some observations made in a woman who developed myasthenia gravis after treatment with D-penicillamine." | 3.66 | Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report. ( Naidoo, PD, 1981) |
| "The authors report on 2 personal cases, and review 48 published cases of myasthenia induced by D-penicillamine (D-P) treatment in patients with rheumatoid arthritis." | 3.66 | [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)]. ( Cler, JM; Cottin, S; Hamelin, JP; Lemouroux, P; Rodat, G; Rodat, O; Rossard, A, 1981) |
| "Immunological and electrophysiological features were investigated in a patient with rheumatoid arthritis who developed myasthenic symptoms after 10 months of treatment with D-penicillamine (D-pen)." | 3.66 | D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies. ( Argov, Z; Fawcett, PR; Mastaglia, FL; McLachlan, SM; Nicholson, LV, 1982) |
| "A woman with rheumatoid arthritis was treated with penicillamine and developed myasthenia gravis." | 3.66 | Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor. ( Lindstrom, JM; Russell, AS, 1978) |
| "Autoimmune diseases, including myasthenia gravis, occur in patients treated with D-penicillamine." | 3.66 | Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. ( Bever, CT; Bock, E; Chang, HW; Jaffe, IA; Penn, AS, 1982) |
| "The clinical features and genetic background of 18 patients with rheumatoid arthritis were investigated following the development of penicillamine-induced myasthenia (PIM)." | 3.66 | Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features. ( Delamere, JP; Jobson, S; Mackintosh, LP; Walton, KW; Wells, L, 1983) |
| "Antibodies to the acetylcholine receptor and HLA antigens have been studied in patients with myasthenia gravis occurring in association with penicillamine treatment." | 3.66 | HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. ( Christiansen, FT; Dawkins, RL; Garlepp, MJ, 1983) |
| "Electroneuromyographic studies have been reported as abnormal in only 9 of 23 cases of penicillamine-associated myasthenia gravis (MG)." | 3.66 | Penicillamine-associated myasthenia gravis. ( Albers, JW; Hodach, RJ; Kimmel, DW; Treacy, WL, 1980) |
| "Skin rashes, proteinuria, systemic lupus erythematosus, polymyositis and myasthenia gravis have all been recorded as complications of penicillamine therapy in patients with rheumatoid arthritis." | 3.66 | Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis. ( Essigman, WK, 1982) |
| "The clinical and electrophysiological findings in 2 men who had developed a myasthenic syndrome after taking penicillamine for rheumatoid arthritis will be described." | 3.66 | [Myasthenic syndrome during penicillamine treatment (author's transl)]. ( Schumm, F; Stöhr, M, 1978) |
| "A 59-year-old woman has been treated for 5 months with penicillamine for a rheumatoid arthritis and developed a myasthenia syndrome with ptosis, diplopia, dysphagia and asthenia." | 3.66 | [Myasthenia syndrome after peroral treatment with penicillamine]. ( Francois, J; Gabriel, P; Verbraeken, H; Wille, C, 1978) |
| "Myasthenia gravis with thymic hyperplasia developed in a patient with Wilson's disease after eight years of penicillamine treatment." | 3.65 | Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. ( Dawkins, RL; Leedman, RJ; Masters, CL; Simpson, JA; Zilko, PJ, 1977) |
| "This report concerns a 55-year-old woman who developed ocular myasthenia after 12 months treatment with D-Penicillamine for her rheumatoid arthritis." | 3.65 | [Ocular myasthenia caused by D-penicillamine (author's transl)]. ( Kommerell, G; Schmidt, D, 1976) |
| "A myasthenic reaction developed after an average latency of seven to eight months in 12 female patients (average age 51 years) treated with penicillamine for chronic rheumatoid arthritis." | 3.65 | [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)]. ( Hopf, HC; Janzen, RW; Meyer, W; Seitz, D, 1976) |
| ") developed myasthenia gravis after taking penicillamine." | 3.65 | Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. ( Bucknall, RC; Dixon A St, J; Glick, EN; Woodland, J; Zutshi, DW, 1975) |
| "Myasthenia gravis is a disease of the neuromuscular junction in which normal transmission of the neuron-to-muscle impulse is impaired or prevented by acetylcholine receptor antibodies." | 2.40 | Drugs and myasthenia gravis. An update. ( Wittbrodt, ET, 1997) |
| "Pemphigus is an autoimmune intraepidermal bullous disease involving the skin and mucous membranes." | 2.36 | Pemphigus: current concepts. ( , 1980) |
| " Our patient is one of three siblings on Penicillamine, she was the only one who developed massive breast enlargement four months after commencing Penicillamine therapy, as well as dermatological adverse reactions and myasthenia gravis three more months later." | 1.38 | Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient. ( Latif, SA; Poh, WY; Tan, SS, 2012) |
| " Adverse effects occurred more frequently after rapid increases in dosage." | 1.27 | The toxicity of D-penicillamine in systemic sclerosis. ( Blair, S; Medsger, TA; Steen, VD, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 90 (73.77) | 18.7374 |
| 1990's | 24 (19.67) | 18.2507 |
| 2000's | 4 (3.28) | 29.6817 |
| 2010's | 3 (2.46) | 24.3611 |
| 2020's | 1 (0.82) | 2.80 |
| Authors | Studies |
|---|---|
| Thapa, L | 1 |
| Thapa, M | 1 |
| Bhattarai, S | 1 |
| Shrestha, AM | 1 |
| Sharma, N | 1 |
| Rai, N | 1 |
| Pokharel, M | 1 |
| Paudel, R | 1 |
| Poulas, K | 1 |
| Koutsouraki, E | 1 |
| Kordas, G | 1 |
| Kokla, A | 1 |
| Tzartos, SJ | 2 |
| Tan, SS | 1 |
| Latif, SA | 1 |
| Poh, WY | 1 |
| Elsais, A | 1 |
| Popperud, TH | 1 |
| Melien, Ø | 1 |
| Kerty, E | 1 |
| McCann, P | 1 |
| Pramanik, A | 1 |
| Komal Kumar, RN | 1 |
| Patil, SA | 1 |
| Taly, AB | 1 |
| Nirmala, M | 1 |
| Sinha, S | 1 |
| Arunodaya, GR | 1 |
| Motomura, M | 1 |
| Shiraishi, H | 1 |
| Yoshimura, T | 1 |
| Tsujihata, M | 1 |
| Argov, Z | 3 |
| Nicholson, L | 1 |
| Fawcett, PR | 2 |
| Mastaglia, FL | 3 |
| Hall, M | 1 |
| Kaeser, HE | 1 |
| Essigman, WK | 1 |
| Albers, JW | 1 |
| Hodach, RJ | 1 |
| Kimmel, DW | 1 |
| Treacy, WL | 1 |
| Garlepp, MJ | 4 |
| Dawkins, RL | 8 |
| Christiansen, FT | 4 |
| Vincent, A | 5 |
| Newsom-Davis, J | 6 |
| Garlepp, MI | 1 |
| Moore, AP | 1 |
| Williams, AC | 1 |
| Hillenbrand, P | 1 |
| Bever, CT | 2 |
| Dretchen, KL | 1 |
| Blake, GJ | 1 |
| Chang, HW | 2 |
| Penn, AS | 4 |
| Asofsky, R | 1 |
| Blanloeil, Y | 2 |
| Baron, D | 2 |
| Nicolas, F | 2 |
| George, J | 1 |
| Spokes, EG | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| Cossermelli, W | 1 |
| De Assis, JL | 1 |
| Delamere, JP | 1 |
| Jobson, S | 1 |
| Mackintosh, LP | 1 |
| Wells, L | 1 |
| Walton, KW | 1 |
| Berstad, J | 1 |
| Marcus, SN | 1 |
| Chadwick, D | 1 |
| Walker, RJ | 1 |
| Myers, A | 1 |
| Songcharoen, S | 1 |
| Harisdangkul, V | 1 |
| Murros, K | 1 |
| Möttönen, T | 1 |
| Scadding, G | 1 |
| Smith, CI | 1 |
| Hammarström, L | 1 |
| Matell, G | 1 |
| Nilsson, BY | 1 |
| Jaffe, IA | 2 |
| Bock, E | 1 |
| Burres, SA | 1 |
| Kanter, ME | 1 |
| Richman, DP | 1 |
| Arnason, BG | 1 |
| Weinzierl, M | 1 |
| Kruis, W | 1 |
| Eisenburg, J | 1 |
| McVicker, JH | 1 |
| Lava, NS | 1 |
| Mittag, TW | 1 |
| Ringel, SP | 1 |
| McLachlan, SM | 1 |
| Nicholson, LV | 1 |
| Woimant, F | 1 |
| Benacin, L | 1 |
| Delauche, MC | 1 |
| Haguenau, M | 1 |
| Pepin, B | 1 |
| Gietka, A | 1 |
| Rodat, O | 1 |
| Hamelin, JP | 1 |
| Rossard, A | 1 |
| Cottin, S | 1 |
| Cler, JM | 1 |
| Rodat, G | 1 |
| Lemouroux, P | 1 |
| Naidoo, PD | 1 |
| Hoshi, K | 1 |
| Mizushima, Y | 1 |
| Kimbrough, RL | 1 |
| Mewis, L | 1 |
| Stewart, RH | 1 |
| Siame, JL | 1 |
| Duquesnoy, B | 1 |
| Lehembre, P | 1 |
| O'Brien, WM | 1 |
| Torres, CF | 1 |
| Griggs, RC | 1 |
| Baum, J | 1 |
| Heyn, J | 1 |
| Suzuki, H | 1 |
| Imai, H | 1 |
| Shiokawa, Y | 1 |
| Bocanegra, T | 1 |
| Espinoza, LR | 1 |
| Vasey, FB | 1 |
| Germain, BF | 1 |
| Gazeau, MF | 1 |
| Andonopoulos, AP | 1 |
| Terzis, E | 1 |
| Tsibri, E | 1 |
| Papasteriades, CA | 1 |
| Papapetropoulos, T | 1 |
| Seideman, P | 1 |
| Ayesh, R | 1 |
| Adelman, HM | 1 |
| Winters, PR | 1 |
| Mahan, CS | 1 |
| Wallach, PM | 1 |
| Héraud, A | 1 |
| Dromer, C | 1 |
| Fatout, E | 1 |
| Fournié, B | 1 |
| Fournié, A | 1 |
| Raynauld, JP | 1 |
| Lee, YS | 1 |
| Kornfeld, P | 1 |
| Fries, JF | 1 |
| Frey, RA | 1 |
| Keller, F | 1 |
| Michel, BA | 1 |
| Jones, E | 1 |
| Sobkowski, WW | 1 |
| Murray, SJ | 1 |
| Walsh, NM | 1 |
| Ferro, J | 1 |
| Susano, R | 1 |
| Gómez, C | 1 |
| de Quirós, JF | 1 |
| Ciompi, ML | 1 |
| Marchetti, G | 1 |
| Bazzichi, L | 1 |
| Puccetti, L | 1 |
| Agelli, M | 1 |
| Brüggemann, W | 1 |
| Herath, H | 1 |
| Ferbert, A | 2 |
| Sanz Gallego, PJ | 1 |
| Pérez Sánchez, FC | 1 |
| López Vázquez, A | 1 |
| Salgado Palacio, D | 1 |
| Wittbrodt, ET | 1 |
| Kato, Y | 1 |
| Naito, Y | 1 |
| Narita, Y | 1 |
| Kuzuhara, S | 1 |
| Chuah, SY | 1 |
| Wong, NW | 1 |
| Goh, KL | 1 |
| Low, BW | 1 |
| Luo, L | 1 |
| Jacques, JJ | 1 |
| Susa, S | 1 |
| Akiba, J | 1 |
| Kurimura, M | 1 |
| Kurita, K | 1 |
| Daimon, M | 1 |
| Manaka, H | 1 |
| Yamatani, K | 1 |
| Kato, T | 1 |
| Jan, V | 1 |
| Callens, A | 1 |
| Machet, L | 1 |
| Machet, MC | 1 |
| Lorette, G | 1 |
| Vaillant, L | 1 |
| Hill, M | 1 |
| Moss, P | 1 |
| Wordsworth, P | 1 |
| Willcox, N | 1 |
| Narayanan, CS | 1 |
| Behari, M | 1 |
| Nishida, H | 1 |
| Sahashi, K | 1 |
| Martin, V | 1 |
| Bucknall, RC | 3 |
| Krel', AA | 1 |
| Ivanova, TS | 1 |
| Balint, G | 1 |
| Sundstrom, WR | 1 |
| Schuna, AA | 1 |
| Russell, AS | 1 |
| Lindstrom, JM | 1 |
| Trnavský, K | 1 |
| Zbojanová, M | 1 |
| Keesey, J | 1 |
| Novom, S | 1 |
| Schumm, F | 1 |
| Stöhr, M | 1 |
| Rosenberger, K | 2 |
| Winter, H | 1 |
| Adams, AE | 1 |
| Ongerboer de Visser, BW | 1 |
| van Soesbergen, RM | 1 |
| Francois, J | 2 |
| Verbraeken, H | 2 |
| Gabriel, P | 2 |
| Wille, C | 2 |
| Gordon, RA | 1 |
| Burnside, JW | 1 |
| Masters, CL | 1 |
| Zilko, PJ | 3 |
| Simpson, JA | 1 |
| Leedman, RJ | 1 |
| Schmidt, D | 1 |
| Kommerell, G | 1 |
| Seitz, D | 1 |
| Hopf, HC | 1 |
| Janzen, RW | 1 |
| Meyer, W | 1 |
| Delrieu, F | 3 |
| Menkes, CJ | 3 |
| Sainte-Croix, A | 2 |
| Babinet, P | 2 |
| Chesneau, AM | 2 |
| Delbarre, F | 2 |
| Dixon A St, J | 1 |
| Glick, EN | 1 |
| Woodland, J | 1 |
| Zutshi, DW | 1 |
| Yates, A | 1 |
| Czlonkowska, A | 1 |
| Owen, ET | 1 |
| Topaktas, S | 1 |
| Dalkara, T | 1 |
| Onur, R | 1 |
| Ruacan, S | 1 |
| Dubost, JJ | 1 |
| Soubrier, M | 1 |
| Bouchet, F | 1 |
| Kemeny, JL | 1 |
| Lhopitaux, R | 1 |
| Bussière, JL | 1 |
| Sauvezie, B | 1 |
| Kuriyama, S | 1 |
| Hosoya, T | 1 |
| Sakai, O | 1 |
| Morel, E | 3 |
| Feuillet-Fieux, MN | 2 |
| Vernet-der Garabedian, B | 1 |
| Raimond, F | 2 |
| D'Anglejan, J | 3 |
| Bataille, R | 1 |
| Sany, J | 1 |
| Bach, JF | 2 |
| Liu, GT | 1 |
| Bienfang, DC | 1 |
| Efthimiadis, A | 1 |
| Bustarret, AF | 1 |
| Drosos, AA | 1 |
| Moutsopoulos, HA | 1 |
| Katz, LJ | 1 |
| Lesser, RL | 1 |
| Merikangas, JR | 1 |
| Silverman, JP | 1 |
| Muirden, KD | 2 |
| Kay, PH | 1 |
| Vernet der Garabedian, B | 1 |
| Jacob, L | 1 |
| Steen, VD | 1 |
| Blair, S | 1 |
| Medsger, TA | 1 |
| Meyer, O | 1 |
| Heidenreich, F | 1 |
| Cikes, N | 1 |
| Momoi, MY | 1 |
| Williams, CL | 1 |
| Howard, FM | 1 |
| Hoagland, HC | 1 |
| Whittingham, S | 1 |
| Lennon, VA | 1 |
| Smiley, JD | 1 |
| Moore, SE | 1 |
| Nishitani, H | 1 |
| Derman, H | 1 |
| Théron, HP | 1 |
| Stockman, A | 1 |
| Major, GA | 1 |
| Tait, BD | 1 |
| Property, DN | 1 |
| Mathews, JD | 1 |
| Hannah, MC | 1 |
| McCluskey, J | 1 |
| Carroll, GJ | 1 |
| Will, RK | 1 |
| Peter, JB | 1 |
| Krikunov, VP | 1 |
| Gubar', EE | 1 |
| Mogucheva, IV | 1 |
| Shagal, DI | 1 |
| Carter, H | 1 |
| Job-Deslandre, C | 1 |
| Kahan, A | 1 |
| Hearn, J | 1 |
| Tiliakos, NA | 1 |
| Fried, MJ | 1 |
| Protheroe, DT | 1 |
| Kuncl, RW | 1 |
| Pestronk, A | 1 |
| Drachman, DB | 1 |
| Rechthand, E | 1 |
| O'Keefe, M | 1 |
| Morley, KD | 1 |
| Haining, WM | 1 |
| Smith, A | 1 |
| Devogelaer, JP | 1 |
| Isaac, G | 1 |
| Noël, H | 1 |
| De Bruyère, M | 1 |
| Huaux, JP | 1 |
| Nagant de Deuxchaisnes, C | 1 |
15 reviews available for penicillamine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
[Adverse effects of therapeutic drugs on neuromuscular junctions].
Topics: Aminoglycosides; Anti-Bacterial Agents; Autoantibodies; Benzodiazepines; Cholinesterase Inhibitors; | 2007 |
Drug-induced myasthenic syndromes.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Autoimmune Diseas | 1984 |
Pemphigus: current concepts.
Topics: Acantholysis; Adrenal Cortex Hormones; Autoimmune Diseases; Binding Sites, Antibody; Gold; Humans; I | 1980 |
Drugs and myasthenia gravis. An update.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Humans; Myasthenia Gravis; Penicillamine; Synaptic Tr | 1997 |
Drug-induced autoimmune myasthenia gravis.
Topics: Animals; Antibody Formation; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Lymphocyte Cultu | 1998 |
[Penicillamine-induced myasthenia gravis].
Topics: Animals; Autoantibodies; Cholinesterase Inhibitors; Humans; Myasthenia Gravis; Penicillamine; Plasma | 2001 |
[Clinical use of d-penicillamine, complications and possibilities of their prevention].
Topics: Collagen Diseases; Dose-Response Relationship, Drug; Drug Eruptions; Drug Evaluation; Drug Hypersens | 1977 |
Drug therapy: Disorders of neuromuscular transmission caused by drugs.
Topics: Aged; Animals; Anti-Bacterial Agents; Anticonvulsants; Cardiovascular Agents; Chloroquine; Drug-Rela | 1979 |
Tissue-specific antibodies in myasthenia gravis.
Topics: Acetylcholine; Antibody Specificity; Antigen-Antibody Complex; Autoantibodies; Binding, Competitive; | 1979 |
[Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
Topics: Aged; Arthritis, Rheumatoid; Female; Graves Disease; Humans; Male; Middle Aged; Myasthenia Gravis; M | 1992 |
[D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1991 |
[D-penicillamine-induced ocular myasthenia in psoriatic arthritis].
Topics: Accessory Nerve; Arthritis, Psoriatic; Humans; Male; Middle Aged; Myasthenia Gravis; Ophthalmoplegia | 1989 |
Ocular myasthenia gravis after D-penicillamine administration.
Topics: Aged; Blepharoptosis; Diplopia; Female; Humans; Myasthenia Gravis; Penicillamine | 1989 |
The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
Topics: Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Captopril; Chloroquine; Clinical T | 1986 |
Molecular mechanisms of autoimmunity.
Topics: Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; B-Lymphocytes; DNA; Humans; Immunoglob | 1988 |
2 trials available for penicillamine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
Topics: Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Captopril; Chloroquine; Clinical T | 1986 |
Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Drug | 1987 |
106 other studies available for penicillamine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Myasthenia Gravis; Penicillamine | 2022 |
Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
Topics: Aged; Antirheumatic Agents; Autoantibodies; Autoantigens; Female; Humans; Myasthenia Gravis; Penicil | 2012 |
Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient.
Topics: Adolescent; Breast; Chelating Agents; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; | 2012 |
[Drugs that may trigger or exacerbate myasthenia gravis].
Topics: Acetylcholine; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Aminoglycosides; Analgesics; An | 2013 |
Dysphagia and unexpected myasthenia gravis associated with primary biliary cirrhosis, ulcerative colitis and vitiligo.
Topics: Aged; Colitis, Ulcerative; Deglutition Disorders; Humans; Liver Cirrhosis, Biliary; Male; Myasthenia | 2004 |
Effect of D-penicillamine on neuromuscular junction in patients with Wilson disease.
Topics: Adolescent; Adult; Autoantibodies; Child; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; | 2004 |
Neuromuscular transmission and acetylcholine receptor antibodies in rheumatoid arthritis patients on D-penicillamine.
Topics: Arthritis, Rheumatoid; Autoantibodies; Female; Humans; Middle Aged; Myasthenia Gravis; Neuromuscular | 1980 |
Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Drug Eruptions; Humans; Lupus Erythematosus, Systemic; Male; Myastheni | 1982 |
Penicillamine-associated myasthenia gravis.
Topics: Arthritis, Rheumatoid; Electromyography; Female; Humans; Immunity, Cellular; Lymphocytes; Male; Midd | 1980 |
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Autoantibodies; Female; Histocompatibility Antigens Class II; HL | 1983 |
HLA antigens in penicillamine induced myasthenia gravis.
Topics: HLA Antigens; Humans; Myasthenia Gravis; Penicillamine; Receptors, Cholinergic | 1983 |
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
Topics: Autoantibodies; Cross Reactions; HLA Antigens; Humans; Myasthenia Gravis; Penicillamine; Receptors, | 1983 |
Penicillamine induced myasthenia reactivated by gold.
Topics: Female; Gold Sodium Thiomalate; Humans; Middle Aged; Myasthenia Gravis; Penicillamine; Recurrence | 1984 |
Augmented anti-acetylcholine receptor response following long-term penicillamine administration.
Topics: Animals; Autoantibodies; Edrophonium; Female; Long-Term Care; Membrane Potentials; Mice; Mice, Inbre | 1984 |
[Myasthenic syndrome induced by D-penicillamine. Danger of curarization].
Topics: Adult; Female; Humans; Myasthenia Gravis; Neuromuscular Nondepolarizing Agents; Penicillamine | 1980 |
Myasthenic pseudo-internuclear ophthalmoplegia due to penicillamine.
Topics: Arthritis, Rheumatoid; Humans; Male; Middle Aged; Myasthenia Gravis; Ophthalmoplegia; Penicillamine | 1984 |
[Myasthenia gravis induced by D-penicillamine in a patient with progressive systemic sclerosis].
Topics: Adult; Autoimmune Diseases; Female; Humans; Myasthenia Gravis; Neuromuscular Junction; Penicillamine | 1984 |
[Penicillamine-induced myasthenia gravis].
Topics: Histocompatibility Antigens Class II; HLA Antigens; HLA-DR Antigens; Humans; Myasthenia Gravis; Peni | 1983 |
Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.
Topics: Adult; Aged; Arthritis, Rheumatoid; Complement System Proteins; Female; Histocompatibility Antigens | 1983 |
[Myasthenia gravis induced by D-penicillamine].
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1983 |
D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
Topics: Autoantibodies; Electromyography; Female; Humans; Liver Cirrhosis; Middle Aged; Myasthenia Gravis; P | 1984 |
Penicillamine-induced myasthenia gravis.
Topics: Arthritis, Rheumatoid; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillamine | 1984 |
[D-penicillamine-induced myasthenia gravis].
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Myasthenia Gravis; Penicillamine | 1984 |
D-pen associated MG.
Topics: Autoantibodies; Humans; Myasthenia Gravis; Penicillamine | 1983 |
Role of penicillamine for the induction of myasthenia gravis.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; DNA; Lymphocytes; Mice; Mice, Inbred Strains; Mice, | 1983 |
Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor.
Topics: Acetylcholine; Animals; Binding Sites; Bungarotoxins; Myasthenia Gravis; Penicillamine; Receptors, C | 1982 |
Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis.
Topics: Adult; Aged; Autoantibodies; Eye Diseases; Female; HLA Antigens; Humans; Male; Middle Aged; Myasthen | 1981 |
Studies on the pathophysiology of chronic D-penicillamine-induced myasthenia.
Topics: Animals; Antibodies; Binding, Competitive; Bungarotoxins; Female; Guinea Pigs; Lymphocyte Activation | 1981 |
[Myasthenia syndrome in D-penicillamine therapy in primary biliary cirrhosis].
Topics: Adult; Copper; Female; Humans; Liver; Liver Cirrhosis; Myasthenia Gravis; Penicillamine | 1981 |
D-penicillamine-induced neuromuscular disease in guinea pigs.
Topics: Action Potentials; Animals; Autoantibodies; Disease Models, Animal; Electromyography; Extremities; F | 1982 |
D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
Topics: Adult; Arthritis, Rheumatoid; Autoantibodies; Electromyography; Female; Humans; Immunoglobulin G; Im | 1982 |
[Myasthenic syndrome induced by D-penicillamine. Changes in serum levels of acetylcholine receptor antibodies].
Topics: Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine; Receptors, Cholinergic | 1982 |
Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Topics: Adolescent; Adult; Aged; Antibody Affinity; Autoantibodies; Cross Reactions; Female; Humans; Male; M | 1982 |
[Myasthenia gravis pseudoparalytica as a result of penicillamine treatment of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1982 |
[D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
Topics: Adult; Arthritis, Rheumatoid; Autoantibodies; Female; Humans; Middle Aged; Muscles; Myasthenia Gravi | 1981 |
Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report.
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Myasthenia Gravis; Penicillamine | 1981 |
[Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
Topics: Agranulocytosis; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Penici | 1981 |
D-penicillamine and the ocular myasthenic syndrome.
Topics: Arthritis, Rheumatoid; Blepharoptosis; Diplopia; Female; Humans; Middle Aged; Myasthenia Gravis; Pen | 1981 |
[Myasthenia in rheumatoid arthritis treated with D-penicillamine: 2 cases].
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1981 |
Toxicity of D-penicillamine in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Interactions; Gold; Humans; Kid | 1980 |
Penicillamine-induced myasthenia gravis in progressive systemic sclerosis.
Topics: Adult; Female; Humans; Myasthenia Gravis; Penicillamine; Scleroderma, Systemic | 1980 |
[Penicillamine induced myasthenia gravis].
Topics: Aged; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1980 |
[A case of malignant rheumatoid arthritis associated with myasthenia gravis by D-penicillamine treatment (author's transl)].
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1980 |
Myasthenia gravis and penicillamine therapy of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Autoantibodies; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillamine; | 1980 |
[Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia (author's transl)].
Topics: Adult; Alcuronium; Arthritis, Rheumatoid; Female; Humans; Myasthenia Gravis; Neuromuscular Junction; | 1980 |
D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?
Topics: Aged; Arthritis, Rheumatoid; Female; HLA Antigens; Humans; Male; Middle Aged; Myasthenia Gravis; Pen | 1994 |
Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillam | 1994 |
D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Hypoventilation; Lung Diseases, Obstructive; Male; Midd | 1995 |
[Myasthenia caused by D-penicillamine in rheumatoid arthritis].
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Myasthenia Gravis; Penicillamine | 1994 |
Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
Topics: Adult; Arthritis, Rheumatoid; Blepharoptosis; Female; Humans; Myasthenia Gravis; Penicillamine; Scle | 1993 |
[D-penicillamine-induced myasthenia gravis].
Topics: Aged; Arthritis, Rheumatoid; Autoantibodies; Female; Humans; Myasthenia Gravis; Penicillamine; Pyrid | 1994 |
Concurrent pemphigus and myasthenia gravis as manifestations of penicillamine toxicity.
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Pemphigus; Penicillamine | 1993 |
[Myasthenia induced by penicillamine: does an interaction with tricyclic antidepressants exist?].
Topics: Aged; Antidepressive Agents, Tricyclic; Arthritis, Rheumatoid; Autoimmune Diseases; Drug Interaction | 1993 |
D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunocompromised Host; Middle Aged; My | 1995 |
[Follow-up and immunologic findings in drug-induced myasthenia].
Topics: Aged; Antirheumatic Agents; Autoantibodies; Chloroquine; Female; Follow-Up Studies; HLA-DR4 Antigen; | 1996 |
[Myasthenia gravis caused by D-penicillamine].
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Myasthenia Gravis; Penicillamine | 1996 |
D-penicillamine-induced myasthenia gravis in a case of eosinophilic fasciitis.
Topics: Eosinophilia; Fasciitis; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine; Scleroderma, | 1997 |
Lethargy in a patient with cirrhosis.
Topics: Female; Humans; Hyperthyroidism; Liver Cirrhosis, Biliary; Middle Aged; Myasthenia Gravis; Penicilla | 1997 |
[A case of myasthenia gravis caused by D-penicillamine therapy].
Topics: Adult; Antirheumatic Agents; Female; Humans; Myasthenia Gravis; Penicillamine; Plasma Exchange; Scle | 1998 |
[D-penicillamine-induced pemphigus, polymyositis and myasthenia].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Female; Humans; Muscles; Myasthenia Gravi | 1999 |
T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes.
Topics: Aged; Amino Acid Sequence; Antirheumatic Agents; Autoimmune Diseases; Base Sequence; Blood Proteins; | 1999 |
Generalized myasthenia gravis following use of D-pencillamine in Wilson's disease.
Topics: Adult; Female; Hepatolenticular Degeneration; Humans; Myasthenia Gravis; Penicillamine | 1999 |
Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis.
Topics: Acetylcholine; Adult; Arthritis, Rheumatoid; Autoantibodies; Female; Humans; Male; Middle Aged; Myas | 1978 |
Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillamine | 1977 |
Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Humans; Myasthenia Gravis; Penicillamine | 1979 |
Penicillamine-induced myasthenia gravis.
Topics: Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillamine | 1979 |
Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor.
Topics: Adult; Arthritis, Rheumatoid; Autoantibodies; Female; Humans; Myasthenia Gravis; Penicillamine; Rece | 1978 |
[Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
Topics: Ageusia; Arthritis, Rheumatoid; Humans; Kidney Diseases; Myasthenia Gravis; Penicillamine; Proteinur | 1979 |
HLA antigens in pencillamine-induced myasthenia gravis.
Topics: Female; HLA Antigens; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1979 |
[Myasthenic syndrome during penicillamine treatment (author's transl)].
Topics: Adult; Arthritis, Rheumatoid; Cholinesterase Inhibitors; Electrophysiology; Humans; Male; Middle Age | 1978 |
[Myasthenic reactions during penicillin therapy].
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1978 |
[Initiation of myasthentic reactions by means of d-penicillamine (author's transl1].
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Cholinesterase Inhibitors; Female; Humans; Male; Mid | 1978 |
[Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1978 |
[Myasthenia syndrome after peroral treatment with penicillamine].
Topics: Arthritis, Rheumatoid; Blepharoptosis; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1978 |
[Myasthenic syndrome following oral treatment with penicillamine].
Topics: Arthritis, Rheumatoid; Blepharoptosis; Deglutition Disorders; Diplopia; Female; Humans; Middle Aged; | 1978 |
D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Myasthenia Gravis; Penicillamine | 1977 |
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies.
Topics: Acetylcholine; Adult; Aged; Antibodies; Arthritis, Rheumatoid; Female; Humans; Immunoglobulin G; Mal | 1977 |
[Ocular myasthenia caused by D-penicillamine (author's transl)].
Topics: Adult; Arthritis, Rheumatoid; Eye Diseases; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Pe | 1976 |
[Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
Topics: Adult; Aged; Arthritis, Rheumatoid; Cholinesterase Inhibitors; Chronic Disease; Female; Humans; Midd | 1976 |
[Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
Topics: Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Female; Humans; Middle Aged; Myasthenia | 1976 |
Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Myasthen | 1975 |
Letter: Myasthenia associated with penicillamine treatment.
Topics: Diagnosis, Differential; Electromyography; Humans; Muscular Diseases; Myasthenia Gravis; Neomycin; P | 1975 |
Myasthenia syndrome during penicillamine treatment.
Topics: Adolescent; Hepatolenticular Degeneration; Humans; Male; Myasthenia Gravis; Penicillamine; Time Fact | 1975 |
Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis.
Topics: Autoantibodies; Humans; Myasthenia Gravis; Penicillamine; Time Factors | 1975 |
[Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Female; Humans; Middle Aged; Myasthenia Gravis; Penicill | 1975 |
Intrathymic injection of D-penicillamine does not induce myasthenia-like disorder in the mouse and rat.
Topics: Animals; Injections; Mice; Mice, Inbred Strains; Myasthenia Gravis; Penicillamine; Rats; Rats, Inbre | 1992 |
Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis.
Topics: Adult; Aged; Antibodies, Antinuclear; Arthritis, Rheumatoid; Autoantibodies; Enzyme-Linked Immunosor | 1991 |
Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Diplopia; Female; Humans; Middle Aged; Myasthenia Gravis; Ocular Motility Dis | 1990 |
Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.
Topics: Adult; Aged; Aged, 80 and over; Antibody Formation; Arthritis, Rheumatoid; Binding, Competitive; Epi | 1988 |
Immunogenetics of spontaneous, drug-induced, and experimental myasthenia gravis.
Topics: Animals; Autoantigens; Female; Genes, Immunoglobulin; Humans; Major Histocompatibility Complex; Male | 1987 |
[Myasthenia induced by D-penicillamine. Study of immuno-clinical correlations in 23 cases].
Topics: Adult; Aged; Antibodies, Antinuclear; Autoantibodies; Female; Humans; Male; Middle Aged; Myasthenia | 1985 |
The toxicity of D-penicillamine in systemic sclerosis.
Topics: Arthritis, Rheumatoid; Digestive System Diseases; Dose-Response Relationship, Drug; Drug Eruptions; | 1986 |
[D-penicillamine: mechanism of cellular action and induced autoimmune diseases].
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Autoimmune Diseases; Dermatomyositis; Humans; Lu | 1986 |
Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myasthenia.
Topics: Adolescent; Adult; Aged; Antibody Specificity; Autoantibodies; Child; Female; Humans; Male; Middle A | 1988 |
Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Bone Marrow Transplantation; Child; Chil | 1988 |
[Receptor abnormalities and diseases. Myasthenia gravis and auto antibodies].
Topics: Adult; Autoantibodies; Female; Humans; Immunoglobulin G; Male; Myasthenia Gravis; Penicillamine; Rec | 1987 |
[3 cases of myasthenic syndrome induced by D-penicillamine].
Topics: Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillamine | 1987 |
Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
Topics: Arthritis, Rheumatoid; Disease Susceptibility; Genetic Markers; Histocompatibility Antigens Class II | 1986 |
Penicillamine induced polymyositis and dermatomyositis.
Topics: Adult; Aged; Antibodies, Antinuclear; Arthritis, Rheumatoid; Autoantibodies; Dermatomyositis; Female | 1987 |
[Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillamine | 1987 |
[Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Penicillam | 1986 |
Myasthenia gravis caused by penicillamine and chloroquine therapy for rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Chloroquine; Dose-Response Relationship, Drug; Humans; Male; Myastheni | 1986 |
D-penicillamine induced myasthenia gravis. Its relevance for the anaesthetist.
Topics: Apnea; Arthritis, Rheumatoid; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine; Postope | 1986 |
The pathophysiology of penicillamine-induced myasthenia gravis.
Topics: Animals; Antibodies; Humans; Male; Middle Aged; Myasthenia Gravis; Neuromuscular Junction; Penicilla | 1986 |
Penicillamine-induced ocular myasthenia gravis.
Topics: Eye Diseases; Female; Humans; Middle Aged; Myasthenia Gravis; Penicillamine | 1985 |
Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Myositis; Neurom | 1985 |